Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib

OBJECTIVES: Effective therapy for non–small-cell lung cancer (NSCLC) depends on morphological and genomic classification, with comprehensive screening for guideline-recommended biomarkers critical to guide treatment. Companion diagnostics, which provide robust genotyping results, represent an import...

Descripción completa

Detalles Bibliográficos
Autores principales: Bauml, Joshua M., Li, Bob T., Velcheti, Vamsidhar, Govindan, Ramaswamy, Curioni-Fontecedro, Alessandra, Dooms, Christophe, Takahashi, Toshiaki, Duda, Andrew W., Odegaard, Justin I., Cruz-Guilloty, Fernando, Jin, Liming, Zhang, Ying, Anderson, Abraham, Skoulidis, Ferdinandos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325630/
https://www.ncbi.nlm.nih.gov/pubmed/34838325
http://dx.doi.org/10.1016/j.lungcan.2021.10.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325630/
https://www.ncbi.nlm.nih.gov/pubmed/34838325
http://dx.doi.org/10.1016/j.lungcan.2021.10.007

Ejemplares similares